These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 262510

  • 1. Influenza virus split vaccines. Effect of priming infection on serologic response in humans.
    Niculescu IT, Zilisteanu E, Cretescu L, Matepiuc M, Dumitrescu R, Oprescu E, Bodnar C, Cuteanu I, Vlad A, Mogos A.
    Arch Roum Pathol Exp Microbiol; 1979; 38(2):147-54. PubMed ID: 262510
    [No Abstract] [Full Text] [Related]

  • 2. Immunogenicity and protective efficacy of influenza vaccination.
    Hannoun C, Megas F, Piercy J.
    Virus Res; 2004 Jul; 103(1-2):133-8. PubMed ID: 15163501
    [No Abstract] [Full Text] [Related]

  • 3. [Inactivated influenza vaccine (H1N1, H3N2, H3N1) - antibody response and protective effect in the influenza epidemic H1N1 in 1979 (author's transl)].
    Bruj J, Skocil V, Farník J, Hronovský F, Síp J.
    Cesk Epidemiol Mikrobiol Imunol; 1981 Sep; 30(5):287-93. PubMed ID: 6456837
    [No Abstract] [Full Text] [Related]

  • 4. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
    Maeda A, Oishi I, Minekawa Y, Kunita N, Funahashi S, Yagura H.
    Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
    [No Abstract] [Full Text] [Related]

  • 5. [Comparative evaluation of influenza antibody titers in enzyme immunoassays and other serologic reactions following preventive vaccination and in influenza patients].
    Schmidt J, Adamczyk B, Gruhn I, Oehring H, Süss J, Vogt KH, Brunnemann H, Michaelis I, Schmidt S, Kittlick M.
    Z Gesamte Hyg; 1984 Aug; 30(8):436-41. PubMed ID: 6385499
    [No Abstract] [Full Text] [Related]

  • 6. Influenza serosurvey for 1988-1989 season.
    Weber JM, Ellis E.
    Can Dis Wkly Rep; 1989 Mar 11; 15(10):55-7. PubMed ID: 2702698
    [No Abstract] [Full Text] [Related]

  • 7. Studies of the 1996-1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness.
    Hurwitz ES, Haber M, Chang A, Shope T, Teo ST, Giesick JS, Ginsberg MM, Cox NJ.
    J Infect Dis; 2000 Oct 11; 182(4):1218-21. PubMed ID: 10979921
    [Abstract] [Full Text] [Related]

  • 8. [Seroconversion after vaccine with trivalent influenza vaccine during the epidemic season 1990/1 in Poland].
    Brydak L, Rudnicka H, Gut W, Magdzik W, Kańtoch M.
    Przegl Epidemiol; 1992 Oct 11; 46(3):221-9. PubMed ID: 1296247
    [Abstract] [Full Text] [Related]

  • 9. Surveillance of the antibody status to current influenza strains in the Norwegian population. 2: Antibodies to the A/USSR/90/77 (H1N1) virus in various age groups after the second epidemic wave.
    Haaheim LR.
    NIPH Ann; 1980 May 11; 3(1):49-56. PubMed ID: 7454125
    [Abstract] [Full Text] [Related]

  • 10. [Antibody formation and preservation against the envelope antigens of influenza virus subtype A(H3N2) after infection and vaccination].
    Stumpa A, Tůmová B.
    Tr Inst Im Pastera; 1982 May 11; 59():23-8. PubMed ID: 6764986
    [No Abstract] [Full Text] [Related]

  • 11. [Safety of an influenza-split-vaccine in children].
    Schmitt-Grohé S, Banzhoff A, Klaassen B, Zielen S.
    Klin Padiatr; 2001 May 11; 213(6):338-42. PubMed ID: 11713714
    [Abstract] [Full Text] [Related]

  • 12. [Testing of influenza virus vaccines--an international comparison].
    Klett G, Stäber H, Willkommen H.
    Z Gesamte Hyg; 1980 May 11; 26(7):473-86. PubMed ID: 7003931
    [No Abstract] [Full Text] [Related]

  • 13. [Effectiveness of vaccination against influenza A in troop collectives].
    Khokhlov DT, Degtiarev AA, Furgal SM.
    Voen Med Zh; 1987 Dec 11; (12):38-9. PubMed ID: 3441998
    [No Abstract] [Full Text] [Related]

  • 14. Reactogenicity and serologic response to trivalent inactivated A/Texas, A/USSR and B/Hong Kong whole-virus influenza vaccine in human volunteers.
    Lavergne B, Frappier-Davignon L, Chagnon A, Burr-Paxton M, Quevillon M, Pavilanis V, Beaulnes A.
    Can J Public Health; 1980 Dec 11; 71(1):25-31. PubMed ID: 6991090
    [No Abstract] [Full Text] [Related]

  • 15. [Immunogenicity and safety of domestic slit influenza vaccine].
    Zhu XJ, Zhang ZL, Li H, Su X, Guo XH, Chen W, Kou M, Duan WP.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jul 11; 25(7):644. PubMed ID: 15308057
    [No Abstract] [Full Text] [Related]

  • 16. [Use of immunoenzyme analysis to study the immune response of persons inoculated with influenza vaccines and in convalescents].
    Kozhukhov VM, Zhilova GP, Kashkin AP, Meringova LF, Voĭtsekhovskiĭ BL.
    Vopr Virusol; 1985 Jul 11; 30(6):745-9. PubMed ID: 3913138
    [No Abstract] [Full Text] [Related]

  • 17. [Effectiveness of inactivated vaccines against influenza].
    Fridman EA, Peradze TV.
    Tr Inst Im Pastera; 1982 Jul 11; 58():84-94. PubMed ID: 6764983
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.